Cite
Histamine H2 Receptor Antagonists and Heart Failure Risk in Postmenopausal Women: The Women's Health Initiative.
MLA
Larson, Sophia R., et al. “Histamine H2 Receptor Antagonists and Heart Failure Risk in Postmenopausal Women: The Women’s Health Initiative.” Journal of the American Heart Association, vol. 11, no. 5, Mar. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.1161/JAHA.121.024270.
APA
Larson, S. R., Vasbinder, A. L., Reding, K. W., Leary, P. J., Branch, K. R., Shadyab, A. H., Johnson, K. C., Haring, B., Wallace, R., Manson, J. E., Anderson, G., & Cheng, R. K. (2022). Histamine H2 Receptor Antagonists and Heart Failure Risk in Postmenopausal Women: The Women’s Health Initiative. Journal of the American Heart Association, 11(5), 1–9. https://doi.org/10.1161/JAHA.121.024270
Chicago
Larson, Sophia R., Alexi L. Vasbinder, Kerryn W. Reding, Peter J. Leary, Kelley R. Branch, Aladdin H. Shadyab, Karen C. Johnson, et al. 2022. “Histamine H2 Receptor Antagonists and Heart Failure Risk in Postmenopausal Women: The Women’s Health Initiative.” Journal of the American Heart Association 11 (5): 1–9. doi:10.1161/JAHA.121.024270.